Assignee
ELIGO BIOSCIENCE
FR·36 granted patents·17 pending applications·46 citations·filing 2018–2025
Top patents by PatentIndex Score
53 records- 0198US11633348B2Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2022·Granted Apr 25, 2023·4 cites·15 claims
- 0297US11541106B2Method for killing bacteria with an engineered postbioticELIGO BIOSCIENCE·Filed 2022·Granted Jan 3, 2023·7 cites·20 claims
- 0397US11236133B2Chimeric receptor binding proteins for use in bacterial delivery vehiclesELIGO BIOSCIENCE·Filed 2020·Granted Feb 1, 2022·5 cites·21 claims
- 0496US11078490B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2020·Granted Aug 3, 2021·3 cites·20 claims
- 0595US11746352B2Microbiome modulation of a host by delivery of DNA payloads with minimized spreadELIGO BIOSCIENCE·Filed 2021·Granted Sep 5, 2023·3 cites·10 claims
- 0694US11739304B2Production of lytic phagesELIGO BIOSCIENCE·Filed 2022·Granted Aug 29, 2023·2 cites·15 claims
- 0794US11224621B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2021·Granted Jan 18, 2022·4 cites·19 claims
- 0893US11839645B2Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2022·Granted Dec 12, 2023·1 cites·13 claims
- 0993US11690880B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2022·Granted Jul 4, 2023·3 cites·19 claims
- 1092US11512116B2Chimeric receptor binding proteins for use in bacterial delivery vehiclesELIGO BIOSCIENCE·Filed 2021·Granted Nov 29, 2022·1 cites·26 claims
- 1192US10808254B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2019·Granted Oct 20, 2020·4 cites·19 claims
- 1291US11534467B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2022·Granted Dec 27, 2022·1 cites·23 claims
- 1389US12460216B2Phage-derived particles for in situ delivery of DNA payload into C. acnes populationELIGO BIOSCIENCE·Filed 2024·Granted Nov 4, 2025·0 cites·17 claims
- 1489US11208437B2Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehiclesELIGO BIOSCIENCE·Filed 2019·Granted Dec 28, 2021·3 cites·27 claims
- 1588US12454696B2Cutibacterium acnes recombinant phages encoding a human proteinELIGO BIOSCIENCE·Filed 2023·Granted Oct 28, 2025·0 cites·15 claims
- 1688US11970701B2Phage-derived particles for in situ delivery of DNA payload into C. acnes populationELIGO BIOSCIENCE·Filed 2023·Granted Apr 30, 2024·0 cites·8 claims
- 1788US11473093B2Cutibacterium acnes recombinant phages, method of production and uses thereofELIGO BIOSCIENCE·Filed 2021·Granted Oct 18, 2022·1 cites·4 claims
- 1887US11376286B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2021·Granted Jul 5, 2022·1 cites·18 claims
- 1987US2024218380A1Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 2086US2024182870A1Production bacterial cells and use thereof in production methodsELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 2186US2024247238A1Production of lytic phagesELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 2285US11952595B2Production of lytic phagesELIGO BIOSCIENCE·Filed 2023·Granted Apr 9, 2024·0 cites·19 claims
- 2385US11939598B2Production bacterial cells and use thereof in production methodsELIGO BIOSCIENCE·Filed 2023·Granted Mar 26, 2024·0 cites·16 claims
- 2484US11124776B2Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereofELIGO BIOSCIENCE·Filed 2019·Granted Sep 21, 2021·2 cites·17 claims
- 2583US11840695B2Recombinant C. acnes phages comprising transgenesELIGO BIOSCIENCE·Filed 2022·Granted Dec 12, 2023·0 cites·5 claims
- 2682US12214070B2Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2023·Granted Feb 4, 2025·0 cites·15 claims
- 2781US2023279058A1Chimeric receptor binding proteins for use in bacterial delivery vehiclesELIGO BIOSCIENCE·Filed 2023·Application pending·0 cites
- 2880US11697802B2Production bacterial cells and use thereof in production methodsELIGO BIOSCIENCE·Filed 2022·Granted Jul 11, 2023·0 cites·9 claims
- 2980US11584918B2Transcriptional control in prokaryotic cells using DNA-binding repressorsELIGO BIOSCIENCE·Filed 2020·Granted Feb 21, 2023·1 cites·19 claims
- 3080US2023330157A1Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2023·Application pending·0 cites
- 3180US2024209326A1Bacterial delivery vehicle, process of production and uses thereofELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 3279US11820989B2Phage-derived particles for in situ delivery of DNA payload into C. acnes populationELIGO BIOSCIENCE·Filed 2021·Granted Nov 21, 2023·0 cites·18 claims
- 3378US11970716B2Transcriptional control in prokaryotic cells using DNA-binding repressorsELIGO BIOSCIENCE·Filed 2023·Granted Apr 30, 2024·0 cites·25 claims
- 3478US11946056B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2021·Granted Apr 2, 2024·0 cites·15 claims
- 3573US11952594B2Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereofELIGO BIOSCIENCE·Filed 2021·Granted Apr 9, 2024·0 cites·15 claims
- 3673US11661443B2Chimeric receptor binding proteins for use in bacterial delivery vehiclesELIGO BIOSCIENCE·Filed 2019·Granted May 30, 2023·0 cites·11 claims
- 3770US12098372B2Microbiome modulation of a host by delivery of DNA payloads with minimized spreadELIGO BIOSCIENCE·Filed 2023·Granted Sep 24, 2024·0 cites·8 claims
- 3869US11905516B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2018·Granted Feb 20, 2024·0 cites·20 claims
- 3968US2023226129A1Elimination of colonic bacterial driving lethal inflammatory cardiomyopathyELIGO BIOSCIENCE·Filed 2023·Application pending·0 cites
- 4066US2025144006A1Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2025·Application pending·0 cites
- 4165US11617773B2Elimination of colonic bacterial driving lethal inflammatory cardiomyopathyELIGO BIOSCIENCE·Filed 2021·Granted Apr 4, 2023·0 cites·7 claims
- 4265US2023112827A1Bacterial delivery vehicles comprising tracer nucleic acid sequencesELIGO BIOSCIENCE·Filed 2022·Application pending·0 cites
- 4365US2023114520A1Engineered bifidobacterium strains comprising a transgeneELIGO BIOSCIENCE·Filed 2022·Application pending·0 cites
- 4463US11584781B2Chimeric receptor binding proteins resistant to proteolytic degradationELIGO BIOSCIENCE·Filed 2021·Granted Feb 21, 2023·0 cites·17 claims
- 4561US11421222B2Bacterial delivery vehicles comprising tracer nucleic acid sequencesELIGO BIOSCIENCE·Filed 2020·Granted Aug 23, 2022·0 cites·25 claims
- 4661US2023134572A1Chimeric receptor binding proteins resistant to proteolytic degradationELIGO BIOSCIENCE·Filed 2022·Application pending·0 cites
- 4760US2023235361A1Method of containment of nucleic acid vectors introduced in a microbiome populationELIGO BIOSCIENCE·Filed 2021·Application pending·0 cites
- 4859US2023126159A1Engineered bacterial strains comprising a transgeneELIGO BIOSCIENCE·Filed 2022·Application pending·0 cites
- 4958US2022064223A1Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehiclesELIGO BIOSCIENCE·Filed 2021·Application pending·0 cites
- 5057US12414962B2Method for treating C. acnes bacteria-associated diseasesELIGO BIOSCIENCE·Filed 2024·Granted Sep 16, 2025·0 cites·19 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →